- Home
- SBFG vs TIL Comparison
SBFG vs TIL Comparison
Compare SBFG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFG
- TIL
- Stock Information
- Founded
- SBFG 1983
- TIL 2018
- Country
- SBFG United States
- TIL United States
- Employees
- SBFG N/A
- TIL N/A
- Industry
- SBFG Major Banks
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- SBFG Finance
- TIL Health Care
- Exchange
- SBFG Nasdaq
- TIL Nasdaq
- Market Cap
- SBFG 155.9M
- TIL 171.7M
- IPO Year
- SBFG N/A
- TIL 2021
- Fundamental
- Price
- SBFG $21.15
- TIL $18.08
- Analyst Decision
- SBFG
- TIL Buy
- Analyst Count
- SBFG 0
- TIL 5
- Target Price
- SBFG N/A
- TIL $114.00
- AVG Volume (30 Days)
- SBFG 18.7K
- TIL 85.6K
- Earning Date
- SBFG 04-17-2025
- TIL 03-04-2025
- Dividend Yield
- SBFG 2.74%
- TIL N/A
- EPS Growth
- SBFG N/A
- TIL N/A
- EPS
- SBFG 1.72
- TIL N/A
- Revenue
- SBFG $56,774,000.00
- TIL N/A
- Revenue This Year
- SBFG N/A
- TIL N/A
- Revenue Next Year
- SBFG N/A
- TIL N/A
- P/E Ratio
- SBFG $12.32
- TIL N/A
- Revenue Growth
- SBFG 0.08
- TIL N/A
- 52 Week Low
- SBFG $13.01
- TIL $9.62
- 52 Week High
- SBFG $24.48
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- SBFG 54.16
- TIL 44.99
- Support Level
- SBFG $20.14
- TIL $17.87
- Resistance Level
- SBFG $21.98
- TIL $19.61
- Average True Range (ATR)
- SBFG 0.64
- TIL 1.75
- MACD
- SBFG 0.22
- TIL 0.02
- Stochastic Oscillator
- SBFG 76.42
- TIL 37.62
About SBFG SB Financial Group Inc.
SB Financial Group Inc operates as a Holding Company of State Bank and RDSI/DCM. Its activities involve commercial banking, trust, and financial services. It offers a full-range of financial services for consumers and small businesses, including trust services, mortgage banking, wealth management services, commercial and agricultural lending. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit. It earns revenue in the form of interest income.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.